Literature DB >> 26597360

Subjective and objective voice outcomes after transoral laser microsurgery for early glottic cancer.

Daniel S Fink1,2, Haley Sibley1, Melda Kunduk1,2,3, Mell Schexnaildre2, Anagha Kakade1, Collin Sutton1, Andrew J McWhorter1,2.   

Abstract

OBJECTIVES/HYPOTHESIS: Transoral laser microsurgery (TLM) continues to gain popularity as a treatment modality for early glottic cancer. Oncologic outcomes have been well-defined, but there are little data to date describing functional outcomes accounting for stage of resection. STUDY
DESIGN: Retrospective review.
METHODS: We retrospectively reviewed patient-rated voice handicap and observer-rated vocal quality of patients who underwent TLM for early glottic carcinoma. Patients were grouped by European Laryngological Society (ELS) resection type, and the data were combined for ELS type I-III and compared with advanced resections (ELS IV-VI). The Voice Handicap Index (VHI) was used for patient-rated voice outcomes, and voice recordings were graded by two senior speech-language pathologists. Voice recordings and VHI scores were taken preoperatively and at least 1 month postoperatively.
RESULTS: No major complications were encountered. Six of 49 patients underwent repeat resection for suspicious findings with pathology, demonstrating moderate dysplasia in two cases, carcinoma in situ in two cases, and inflamed mucosa only in two cases. There was no significant difference in preoperative VHI scores or objective voice grades among patients who underwent limited (ELS I-III) and those who required more advanced (ELS IV-VI) resection. There was a significant improvement in VHI scores in patients after ELS type I to III resection, from 38.77 to 22.86 (P = .006). There was no significant difference between mean preoperative and postoperative perceptual evaluation scores in patients who underwent ELS type I, II, or III resections (62.25 and 64.32 respectively, P = .621).
CONCLUSIONS: Patients who undergo limited ELS resections can be assured of having a similar to improved voice after healing. Patients who undergo extended resections have poorer vocal outcomes. LEVEL OF EVIDENCE: 4.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Larynx; early glottic cancer; quality of life

Mesh:

Year:  2015        PMID: 26597360     DOI: 10.1002/lary.25442

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  The "Comprehensive ICF Core Set for Head and Neck Cancer": a Delphi consensus survey among German speaking speech and language therapists.

Authors:  Matthias Engelbarts; Vanessa Schuster; Ulrich Kisser; Carla Sabariego; Marita Stier-Jarmer; Michaela Coenen; Benjamin Philipp Ernst; Sebastian Strieth; Ulrich Harréus; Sven Becker
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-24       Impact factor: 2.503

2.  Radiotherapy Versus Surgery-Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms.

Authors:  Yajing Du; Shali Shao; Minghe Lv; Yi Zhu; Li Yan; Tiankui Qiao
Journal:  Front Oncol       Date:  2020-08-26       Impact factor: 6.244

3.  Evolution of voice after transoral laser cordectomy for precancerous lesions and early glottic cancer.

Authors:  Lucia Staníková; Karol Zeleník; Martin Formánek; Jana Seko; Radana Walderová; Peter Kántor; Pavel Komínek
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-03-18       Impact factor: 2.503

Review 4.  Transoral Laser Microsurgery in Early Glottic Lesions.

Authors:  E V Sjögren
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-03-11

5.  Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: Results after 1 year.

Authors:  Yda van Loon; Martine Hendriksma; Bas J Heijnen; Vivienne A H van de Kamp; Marieke M Hakkesteegt; Stefan Böhringer; Ton P M Langeveld; M A de Jong; W Martin C Klop; Robert J Baatenburg de Jong; Elisabeth V Sjögren
Journal:  Head Neck       Date:  2019-01-16       Impact factor: 3.147

6.  Injection laryngoplasty during transoral laser microsurgery for early glottic cancer: a randomized controlled trial.

Authors:  Ayham Al Afif; Matthew H Rigby; Colin MacKay; Timothy F Brown; Timothy J Phillips; Usman Khan; Jonathan R B Trites; Martin Corsten; S Mark Taylor
Journal:  J Otolaryngol Head Neck Surg       Date:  2022-03-22

Review 7.  Voice quality after transoral CO2 laser microsurgery (TOLMS): systematic review of literature.

Authors:  Andrea Colizza; Massimo Ralli; Chiara D'Elia; Antonio Greco; Marco de Vincentiis
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-05-03       Impact factor: 3.236

8.  T1a Glottic Cancer: Advances in Vocal Outcome Assessment after Transoral CO2-Laser Microsurgery Using the VEM.

Authors:  Wen Song; Felix Caffier; Tadeus Nawka; Tatiana Ermakova; Alexios Martin; Dirk Mürbe; Philipp P Caffier
Journal:  J Clin Med       Date:  2021-03-17       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.